secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001558370-23-016208
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic Biopharma appoints Brian Hungerford as CFO with $375K salary, 21,900 RSUs
--------------------------------------------------------------------------------

- Brian Hungerford named CFO effective October 1, 2023; reports to CEO.
- Base salary of $375,000 per year; eligible for annual target bonus of 40% of base salary.
- Granted 21,900 restricted shares vesting on October 1, 2024.
- Severance: 12 months base salary plus bonus/benefits if terminated without cause or for good reason.
- Unvested equity accelerates 24 months post-termination under certain severance conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023016208/0001558370-23-016208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000155837023016208/krbp-20231001x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-016208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer